Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and diurnal variation in maximal fat oxidation in metabolic syndrome
PACTR202510506789089Recruiting
- Sponsor
- Hôpital Universitaire Sahloul
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metformin in cardiometabolic risk (CMR) (4 arms), sponsored by Hôpital Universitaire Sahloul. Started Oct 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on PACTR202510506789089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510506789089.